NO991384L - Substituerte heterocykler som anti-tumormidler - Google Patents
Substituerte heterocykler som anti-tumormidlerInfo
- Publication number
- NO991384L NO991384L NO991384A NO991384A NO991384L NO 991384 L NO991384 L NO 991384L NO 991384 A NO991384 A NO 991384A NO 991384 A NO991384 A NO 991384A NO 991384 L NO991384 L NO 991384L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- formula
- tumor agents
- substituted heterocycles
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Den foreliggende oppfinnelse tilveiebringer forbindelsene fra formel (I) hvori Ri-R?, W, X, Y og Z har enhver av verdiene definert i beskrivelsen, og farmasøytisk akseptable salt derav, som er nyttige som anti-cancermidler. Også beskrevet er farmasøytiske sammensetninger som omfatter en eller flere forbindelser fra formel (I), metoder for fremstilling av forbindelsene fra formel (I) og intermediater nyttige for fremstilling av forbindelser fra formel (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2651196P | 1996-09-23 | 1996-09-23 | |
PCT/US1997/017012 WO1998012181A1 (en) | 1996-09-23 | 1997-09-23 | Substituted heterocycles as anti-tumor agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NO991384D0 NO991384D0 (no) | 1999-03-22 |
NO991384L true NO991384L (no) | 1999-05-20 |
Family
ID=21832257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO991384A NO991384L (no) | 1996-09-23 | 1999-03-22 | Substituerte heterocykler som anti-tumormidler |
Country Status (14)
Country | Link |
---|---|
US (1) | US5981541A (no) |
EP (1) | EP0950054A1 (no) |
JP (1) | JP2001501197A (no) |
KR (1) | KR20000048537A (no) |
AU (1) | AU725938B2 (no) |
BR (1) | BR9711296A (no) |
CA (1) | CA2266321A1 (no) |
CZ (1) | CZ102499A3 (no) |
IL (1) | IL129096A0 (no) |
NO (1) | NO991384L (no) |
NZ (1) | NZ334954A (no) |
PL (1) | PL332416A1 (no) |
TR (1) | TR199900636T2 (no) |
WO (1) | WO1998012181A1 (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL137351A0 (en) | 1998-02-12 | 2001-07-24 | Univ Rutgers | Heterocyclic topoisomerase poisons |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US8133421B2 (en) * | 1999-02-23 | 2012-03-13 | Warsaw Orthopedic, Inc. | Methods of making shaped load-bearing osteoimplant |
US20070233272A1 (en) * | 1999-02-23 | 2007-10-04 | Boyce Todd M | Shaped load-bearing osteoimplant and methods of making same |
US6740650B2 (en) | 1999-10-29 | 2004-05-25 | Rutgers, The State University Of New Jersey | Heterocyclic cytotoxic agents |
GB9928542D0 (en) * | 1999-12-02 | 2000-02-02 | Xenova Ltd | Pharmaceutical compounds |
US20030139409A1 (en) | 1999-12-02 | 2003-07-24 | John Milton | Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II |
JP2003528858A (ja) * | 2000-03-27 | 2003-09-30 | アクゾ・ノベル・エヌ・ベー | エストロゲン関連治療用のノンステロイド系四環式化合物 |
KR100381716B1 (ko) * | 2000-10-09 | 2003-04-26 | 한국화학연구원 | 항암활성을 가지는 아크리딘 유도체 |
MXPA04004607A (es) | 2001-11-14 | 2004-09-10 | Univ Rutgers | Agentes de venenos de topoisomerasa solubilizados. |
EP1465625B1 (en) * | 2001-11-14 | 2010-02-03 | Rutgers, The State University | Solubilized topoisomerase poisons |
EP1453812B1 (en) | 2001-11-14 | 2008-08-20 | Rutgers, The State University | Cytotoxic agents |
EP1453506B1 (en) | 2001-11-14 | 2008-04-02 | Rutgers, The State University | Topoisomerase poison agents |
US6989387B2 (en) | 2002-08-09 | 2006-01-24 | Rutgers, The State University Of New Jersey | Nitro and amino substituted topoisomerase agents |
US6992088B2 (en) * | 2002-08-09 | 2006-01-31 | Rutgers, The State University Of New Jersey | Nitro and amino substituted heterocycles as topoisomerase I targeting agents |
WO2004014906A2 (en) * | 2002-08-09 | 2004-02-19 | Rutgers, The State University | Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents |
EP1562593B1 (en) * | 2002-11-12 | 2014-07-16 | Rutgers, The State University of New Jersey | Topoisomerase-targeting agents |
EP2403856B1 (en) | 2009-03-06 | 2012-12-19 | Rutgers, The State University of New Jersey | Methylenedioxybenzo [i]phenanthridine derivatives used to treat cancer |
WO2010127363A1 (en) | 2009-05-01 | 2010-11-04 | Rutgers, The State University Of New Jersey | Toposiomerase inhibitors |
MX2012013527A (es) * | 2010-05-21 | 2013-04-08 | Shanghai Inst Pharm Industry | Quinazolinas policíclicas, preparación de las mismas, y uso de las mismas. |
CN102351870B (zh) * | 2011-08-25 | 2014-03-12 | 中山大学 | 一种苯并吖啶衍生物的制备方法及其作为抗癌药物的用途 |
CN105669551B (zh) * | 2015-12-02 | 2018-04-17 | 广西中医药大学 | 7‑苯并(c)吖啶对氟苯甲酰胺基硫脲及其制备方法和用途 |
EP3442979A4 (en) | 2016-04-04 | 2019-12-18 | Rutgers, the State University of New Jersey | topoisomerase poisons |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US26065A (en) * | 1859-11-08 | Improvement in cotton-gins | ||
US2981731A (en) * | 1961-04-25 | Acridine derivatives | ||
USRE26065E (en) | 1966-07-19 | Folybenzimidazoles and their preparation | ||
US2985661A (en) * | 1956-02-06 | 1961-05-23 | American Cyanamid Co | Preparation of 2(omicron-aminophenyl)-benzimidazole |
US2915523A (en) * | 1956-12-03 | 1959-12-01 | Parke Davis & Co | Benzacridine compounds |
US3272707A (en) * | 1964-07-17 | 1966-09-13 | Smith Kline French Lab | Pharmaceutical compositions and methods for their use |
CH420045A (de) * | 1964-09-01 | 1967-03-15 | Ciba Geigy | Verwendung von neuen Poly-azolen als optische Aufhellmittel für textile organische Materialien |
US3267107A (en) * | 1964-09-17 | 1966-08-16 | American Home Prod | 3-(4'-5'-methylenedioxy-phenyl)-7, 8-dimethoxy-1, 2, 3, 4,-tetrahydroisoquinolines |
US3849561A (en) * | 1964-10-20 | 1974-11-19 | S Naruto | Anti-peptic ulcer substance from corydalis tubers |
DE1670684A1 (de) * | 1966-04-01 | 1970-12-03 | Hoechst Ag | Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten |
JPS4942700A (no) * | 1972-08-25 | 1974-04-22 | ||
US4980344A (en) * | 1982-05-14 | 1990-12-25 | Maroko Peter R | Compositions for improving circulatory performance |
JPS61130289A (ja) * | 1984-11-29 | 1986-06-18 | Ss Pharmaceut Co Ltd | 13−プロピルベルベリンの塩 |
US5244903A (en) * | 1987-03-31 | 1993-09-14 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
JP2700475B2 (ja) * | 1988-07-30 | 1998-01-21 | コニカ株式会社 | 非線形光学材料および非線形光学素子 |
US4938949A (en) * | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
US5106863A (en) * | 1990-03-26 | 1992-04-21 | Ortho Pharmaceutical Corporation | Substituted imidazole and pyridine derivatives |
US5135934A (en) * | 1990-07-06 | 1992-08-04 | Du Pont Merck Pharmaceutical Company | 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents |
US5126351A (en) * | 1991-01-24 | 1992-06-30 | Glaxo Inc. | Antitumor compounds |
US5223506A (en) * | 1991-06-04 | 1993-06-29 | Glaxo Inc. | Cyclic antitumor compounds |
US5428040A (en) * | 1993-08-31 | 1995-06-27 | The Du Pont Merck Pharmaceutical Company | Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents |
EP0721942B1 (en) * | 1993-09-28 | 2002-06-05 | Kyowa Hakko Kogyo Co., Ltd. | Tetracyclic compound |
-
1997
- 1997-09-23 JP JP10515004A patent/JP2001501197A/ja active Pending
- 1997-09-23 NZ NZ334954A patent/NZ334954A/xx unknown
- 1997-09-23 IL IL12909697A patent/IL129096A0/xx unknown
- 1997-09-23 AU AU45897/97A patent/AU725938B2/en not_active Ceased
- 1997-09-23 KR KR1019990702452A patent/KR20000048537A/ko not_active Application Discontinuation
- 1997-09-23 PL PL97332416A patent/PL332416A1/xx unknown
- 1997-09-23 WO PCT/US1997/017012 patent/WO1998012181A1/en not_active Application Discontinuation
- 1997-09-23 CA CA002266321A patent/CA2266321A1/en not_active Abandoned
- 1997-09-23 CZ CZ991024A patent/CZ102499A3/cs unknown
- 1997-09-23 BR BR9711296A patent/BR9711296A/pt unknown
- 1997-09-23 EP EP97944388A patent/EP0950054A1/en not_active Ceased
- 1997-09-23 US US08/935,777 patent/US5981541A/en not_active Expired - Lifetime
- 1997-09-23 TR TR1999/00636T patent/TR199900636T2/xx unknown
-
1999
- 1999-03-22 NO NO991384A patent/NO991384L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9711296A (pt) | 1999-08-17 |
JP2001501197A (ja) | 2001-01-30 |
CZ102499A3 (cs) | 1999-09-15 |
AU725938B2 (en) | 2000-10-26 |
TR199900636T2 (xx) | 1999-10-21 |
PL332416A1 (en) | 1999-09-13 |
NZ334954A (en) | 2000-08-25 |
NO991384D0 (no) | 1999-03-22 |
IL129096A0 (en) | 2000-02-17 |
KR20000048537A (ko) | 2000-07-25 |
WO1998012181A1 (en) | 1998-03-26 |
CA2266321A1 (en) | 1998-03-26 |
AU4589797A (en) | 1998-04-14 |
EP0950054A1 (en) | 1999-10-20 |
US5981541A (en) | 1999-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO991384L (no) | Substituerte heterocykler som anti-tumormidler | |
DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
NO20085077L (no) | Nye forbindelser | |
NO20050664L (no) | 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer | |
NO20055714L (no) | Inhibitorer av fosfatidylinositol 3-kinase | |
HK1070054A1 (en) | Arylsulfonyl derivatives with5-ht6 receptor affinity | |
ATE316083T1 (de) | Adamantanderivate | |
MX9803954A (es) | Derivados de aminoacidos, composiciones farmaceuticas que contienen estos compuestos y procesos para prepararlos. | |
NO20040881L (no) | Orale antidiabetes midler. | |
EE200200208A (et) | Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
TR199900732T2 (xx) | PDE IV inhibe eden 2-siyanoiminoimidazol t�revleri. | |
EP0992509A3 (en) | Novel macrolide derivatives | |
NO973652D0 (no) | 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyre og derivater som tachykininreseptor-antagonist | |
IS2387B (is) | Æxliseyðandi efni | |
TR200103789T2 (tr) | Tirozin kinaz inhibitörleri olarak ikameli 1,4-dihidroindeno[1,2-C]pirazoller. | |
DE69330601T2 (de) | Serotoninergische ergolin derivate | |
ES8604488A1 (es) | Un procedimiento para la preparacion de un derivado de ace- tileno | |
EP1567508A4 (en) | 1,2,4-TRIAZOLE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
UY27311A1 (es) | Agentes antibacterianos | |
EE03488B1 (et) | Meetod anhüdroekgoniini estrite valmistamiseks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |